Manufacturers, hospitals, physicians and patient advocates have put significant marketing resources—including millions of dollars—into selling 3D mammograms to women, despite little evidence the modality is better than traditional mammography.

“A better understanding of how age and comorbid conditions affect mammography use may help target specific populations and improve use of preventive care," wrote Cindy Yuan, MD, PhD, with the University of Chicago’s Department of Radiology, and colleagues.

The findings were true regardless of tumor type, size or cancer stage, wrote Pragya A. Dang, MD, and colleagues at Brigham and Women’s Hospital in Boston.

Men make up nearly 1% of all breast cancer cases in the U.S., but their mortality rate is drastically higher compared to women diagnosed with the disease.

Deep learning offers similar detection of prostate cancer on MRI compared to prostate imaging reporting and data system (PI-RADS) assessments, according to new research out of Germany.

More than 50% of the 43.7 million foreign-born people living in the U.S. are female—that figure is only expected to grow, explained lead author Tainya Clarke, PhD, MPH.

There is no shortage of research investigating the effectiveness of the Breast Imaging Reporting and Data System (BI-RADS) category 3 in mammography, but what’s less understood is why some women complete follow-up recommendations while many do not.

Breast cancer phenotype can influence MRI’s ability to evaluate the effectiveness of chemotherapy, according to a study published Oct. 4 in the European Journal of Radiology. But which specific tumor subtypes have the greatest impact on the modality’s performance?

A new magnetic “seed” technology can help radiologists localize breast lesions and offers benefits over traditional wire-guided localization (WGL), reported authors of a study published Oct. 3 in the European Journal of Radiology.

The National Cancer Institute—part of the National Institutes of Health (NIH)—has awarded researchers at the University of Arizona Health Sciences $3.6 million to investigate a new imaging-based method to detect breast cancer.

The Radiological Society of North America (RSNA) has published their first issue of Radiology: Imaging Cancer, a new online journal dedicated to the latest in cancer imaging.

“Knowing that the cancer yield of screening US is similar after DBT versus DM may help inform clinical practice, because questions abound about whether DBT is sufficient screening for women with dense breast tissue," wrote authors of a new study published in the American Journal of Roentgenology.